CFA
BMY icon

Capstone Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Capstone Financial Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$754K Sell
12,432
-598
-5% -$34.9K 0.04% 78
2025
Q4 		$703K Sell
13,030
-5,511
-30% -$265K 0.04% 78
2025
Q3 		$836K Buy
18,541
+217
+1% +$10.1K 0.05% 75
2025
Q2 		$848K Buy
18,324
+577
+3% +$28.3K 0.05% 73
2025
Q1 		$1.08M Sell
17,747
-102
-0.6% -$5.95K 0.07% 60
2024
Q4 		$1.01M Sell
17,849
-4,585
-20% -$256K 0.06% 63
2024
Q3 		$1.16M Sell
22,434
-23
-0.1% -$1.08K 0.07% 54
2024
Q2 		$933K Buy
22,457
+319
+1% +$14.3K 0.06% 59
2024
Q1 		$1.2M Buy
22,138
+7,930
+56% +$404K 0.08% 50
2023
Q4 		$729K Sell
14,208
-56
-0.4% -$2.94K 0.05% 64
2023
Q3 		$828K Sell
14,264
-401
-3% -$24.6K 0.07% 56
2023
Q2 		$938K Buy
14,665
+964
+7% +$64.6K 0.07% 54
2023
Q1 		$950K Buy
13,701
+228
+2% +$16.1K 0.08% 51
2022
Q4 		$969K Sell
13,473
-1,112
-8% -$83.8K 0.08% 47
2022
Q3 		$1.04M Sell
14,585
-128
-0.9% -$9.29K 0.1% 46
2022
Q2 		$1.13M Sell
14,713
-582
-4% -$44.3K 0.1% 46
2022
Q1 		$1.12M Buy
15,295
+7,455
+95% +$501K 0.08% 48
2021
Q4 		$489K Buy
7,840
+659
+9% +$38.7K 0.04% 79
2021
Q3 		$425K Buy
7,181
+85
+1% +$5.6K 0.03% 77
2021
Q2 		$474K Buy
7,096
+47
+0.7% +$3.06K 0.04% 73
2021
Q1 		$445K Buy
7,049
+1,851
+36% +$115K 0.04% 69
2020
Q4 		$322K Buy
5,198
+1,348
+35% +$82.9K 0.03% 77
2020
Q3 		$232K Hold
3,850
– – 0.02% 90
2020
Q2 		$226K Hold
3,850
– – 0.03% 83
2020
Q1 		$215K Hold
3,850
– – 0.03% 73
2019
Q4 		$247K Buy
+3,850
New +$220K 0.03% 70

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capstone Financial Advisors's BMY Position: Q1 2026 in Review

Capstone Financial Advisors reduced its Bristol-Myers Squibb (BMY) stake by 4.6% in Q1 2026, selling an estimated $34.9K and leaving 12,432 shares worth $754K. The position accounts for 0.04% of the portfolio, ranked #78.

Capstone Financial Advisors first reported a position in BMY in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.2M in Q1 2024. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Capstone Financial Advisors held 12,432 shares of Bristol-Myers Squibb worth $754K as of Q1 2026.
  • Capstone Financial Advisors sold 598 Bristol-Myers Squibb shares in Q1 2026, an estimated $34.9K.
  • Bristol-Myers Squibb made up 0.04% of Capstone Financial Advisors's portfolio in Q1 2026, its #78 holding.
  • Capstone Financial Advisors first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 26 quarters since.
  • Capstone Financial Advisors's Bristol-Myers Squibb position peaked at $1.2M in Q1 2024.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Capstone Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.